Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith

US10149849B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10149849-B2
Application numberUS-201715641383-A
CountryUS
Kind codeB2
Filing dateJul 5, 2017
Priority dateOct 6, 2014
Publication dateDec 11, 2018
Grant dateDec 11, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided herein are Aminopurine Compounds having the following structures: wherein R 1 , R 2 , and R 3 are as defined herein, compositions comprising an effective amount of an Aminopurine Compound, and methods for treating or preventing a cancer, for example, melanoma.

First claim

Opening claim text (preview).

What is claimed is: 1. A compound of formula (If) wherein: R 1 is substituted or unsubstituted cycloalkylalkyl, or substituted non-aromatic heterocyclyl; R 2 is H or substituted or unsubstituted C 1-3 alkyl; R 3 is phenyl, substituted with one or more halogen, optionally further substituted with one or more substituents selected from substituted or unsubstituted C 1-3 alkyl, CN, and —OR′, wherein each R′ is independently substituted or unsubstituted C 1-3 alkyl; when a C 1-3 alkyl group is substituted, it is independently substituted with chloro, iodo, bromo, fluoro, alkyl, hydroxyl, alkoxy, alkoxyalkyl, amino, alkylamino, carboxy, nitro, cyano, thiol, thioether, imine, imide, amidine, guanidine, enamine, aminocarbonyl, acylamino, phosphonate, phosphine, thiocarbonyl, sulfinyl, sulfone, sulfonamide, ketone, aldehyde, ester, urea, urethane, oxime, hydroxyl amine, alkoxyamine, aryloxyamine, aralkoxyamine, N-oxide, hydrazine, hydrazide, hydrazone, azide, isocyanate, isothiocyanate, cyanate, thiocyanate, B(OH) 2, or O(alkyl)aminocarbonyl; and when a group, with the exception of a C 1-3 alkyl group, is substituted, it is independently substituted with chloro, iodo, bromo, fluoro, alkyl, hydroxyl, alkoxy, alkoxyalkyl, amino, alkylamino, carboxy, nitro, cyano, thiol, thioether, imine, imide, amidine, guanidine, enamine, aminocarbonyl, acylamino, phosphonate, phosphine, thiocarbonyl, sulfinyl, sulfone, sulfonamide, ketone, aldehyde, ester, urea, urethane, oxime, hydroxyl amine, alkoxyamine, aryloxyamine, aralkoxyamine, N-oxide, hydrazine, hydrazide, hydrazone, azide, isocyanate, isothiocyanate, cyanate, thiocyanate, oxygen (═O), B(OH) 2 , O(alkyl)aminocarbonyl, cycloalkyl, heterocyclyl, heteroaryl, aryloxy, aralkyloxy, heterocyclyloxy, or heterocyclyl alkoxy. 2. A compound of formula (Ig) wherein: R 1 is substituted or unsubstituted cycloalkylalkyl, or substituted non-aromatic heterocyclyl; R 2 is H or substituted or unsubstituted C 1-3 alkyl; R 3 is phenyl, substituted with one or more halogen, optionally further substituted with one or more substituents selected from substituted or unsubstituted C 1-3 alkyl, CN, and —OR′, wherein each R′ is independently substituted or unsubstituted C 1-3 alkyl; and R # is C 1-2 alkyl; when a C 1-2 or C 1-3 alkyl group is substituted, it is independently substituted with chloro, iodo, bromo, fluoro, alkyl, hydroxyl, alkoxy, alkoxyalkyl, amino, alkylamino, carboxy, nitro, cyano, thiol, thioether, imine, imide, amidine, guanidine, enamine, aminocarbonyl, acylamino, phosphonate, phosphine, thiocarbonyl, sulfinyl, sulfone, sulfonamide, ketone, aldehyde, ester, urea, urethane, oxime, hydroxyl amine, alkoxyamine, aryloxyamine, aralkoxyamine, N-oxide, hydrazine, hydrazide, hydrazone, azide, isocyanate, isothiocyanate, cyanate, thiocyanate, B(OH) 2, or O(alkyl)aminocarbonyl; and when a group, with the exception of a C 1-2 or C 1-3 alkyl group, is substituted, it is independently substituted with chloro, iodo, bromo, fluoro, alkyl, hydroxyl, alkoxy, alkoxyalkyl, amino, alkylamino, carboxy, nitro, cyano, thiol, thioether, imine, imide, amidine, guanidine, enamine, aminocarbonyl, acylamino, phosphonate, phosphine, thiocarbonyl, sulfinyl, sulfone, sulfonamide, ketone, aldehyde, ester, urea, urethane, oxime, hydroxyl amine, alkoxyamine, aryloxyamine, aralkoxyamine, N-oxide, hydrazine, hydrazide, hydrazone, azide, isocyanate, isothiocyanate, cyanate, thiocyanate, oxygen (═O), B(OH) 2 , O(alkyl)aminocarbonyl, cycloalkyl, heterocyclyl, heteroaryl, aryloxy, aralkyloxy, heterocyclyloxy, or heterocyclyl alkoxy. 3. A compound of formula (Im) wherein: R 1 is substituted or unsubstituted cycloalkylalkyl, or substituted non-aromatic heterocyclyl; R 2 is H or substituted or unsubstituted C 1-3 alkyl; R 3 is phenyl, substituted with one or more halogen, optionally further substituted with one or more substituents selected from substituted or unsubstituted C 1-3 alkyl, CN, and —OR′, wherein each R′ is independently substituted or unsubstituted C 1-3 alkyl; and P is Rink-H resin; when a C 1-3 alkyl group is substituted, it is independently substituted with chloro, iodo, bromo, fluoro, alkyl, hydroxyl, alkoxy, alkoxyalkyl, amino, alkylamino, carboxy, nitro, cyano, thiol, thioether, imine, imide, amidine, guanidine, enamine, aminocarbonyl, acylamino, phosphonate, phosphine, thiocarbonyl, sulfinyl, sulfone, sulfonamide, ketone, aldehyde, ester, urea, urethane, oxime, hydroxyl amine, alkoxyamine, aryloxyamine, aralkoxyamine, N-oxide, hydrazine, hydrazide, hydrazone, azide, isocyanate, isothiocyanate, cyanate, thiocyanate, B(OH) 2 , or O(alkyl)aminocarbonyl; and when a group, with the exception of a C 1-3 alkyl group, is substituted, it is independently substituted with chloro, iodo, bromo, fluoro, alkyl, hydroxyl, alkoxy, alkoxyalkyl, amino, alkylamino, carboxy, nitro, cyano, thiol, thioether, imine, imide, amidine, guanidine, enamine, aminocarbonyl, acylamino, phosphonate, phosphine, thiocarbonyl, sulfinyl, sulfone, sulfonamide, ketone, aldehyde, ester, urea, urethane, oxime, hydroxyl amine, alkoxyamine, aryloxyamine, aralkoxyamine, N-oxide, hydrazine, hydrazide, hydrazone, azide, isocyanate, isothiocyanate, cyanate, thiocyanate, oxygen (═O), B(OH) 2 , O(alkyl)aminocarbonyl, cycloalkyl, heterocyclyl, heteroaryl, aryloxy, aralkyloxy, heterocyclyloxy, or heterocyclyl alkoxy.

Assignees

Inventors

Classifications

  • C07D473/32Primary

    Nitrogen atom · CPC title

  • not condensed and containing further heterocyclic rings, e.g. timolol · CPC title

  • Antineoplastic agents · CPC title

  • A61K31/52Primary

    Purines, e.g. adenine · CPC title

  • Three nitrogen atoms · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10149849B2 cover?
Provided herein are Aminopurine Compounds having the following structures: wherein R 1 , R 2 , and R 3 are as defined herein, compositions comprising an effective amount of an Aminopurine Compound, and methods for treating or preventing a cancer, for example, melanoma.
Who is the assignee on this patent?
Signal Pharm Llc
What technology area does this patent fall under?
Primary CPC classification C07D473/32. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Dec 11 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).